Insider Transactions in Q1 2023 at Vera Therapeutics, Inc. (VERA)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 30
2023
|
Beth C Seidenberg |
BUY
Open market or private purchase
|
Indirect |
2,300
+0.12%
|
$16,100
$7.24 P/Share
|
|
Mar 28
2023
|
Beth C Seidenberg |
BUY
Open market or private purchase
|
Indirect |
23,908
+1.21%
|
$167,356
$7.24 P/Share
|
|
Mar 27
2023
|
Beth C Seidenberg |
BUY
Open market or private purchase
|
Indirect |
1,633
+0.08%
|
$11,431
$7.24 P/Share
|
|
Mar 24
2023
|
Beth C Seidenberg |
BUY
Open market or private purchase
|
Indirect |
1,833
+0.1%
|
$12,831
$7.24 P/Share
|
|
Mar 20
2023
|
Beth C Seidenberg |
BUY
Open market or private purchase
|
Indirect |
15,252
+0.79%
|
$106,764
$7.21 P/Share
|
|
Mar 17
2023
|
Beth C Seidenberg |
BUY
Open market or private purchase
|
Indirect |
74,045
+3.74%
|
$518,315
$7.12 P/Share
|
|
Mar 16
2023
|
Beth C Seidenberg |
BUY
Open market or private purchase
|
Indirect |
60,097
+3.18%
|
$420,679
$7.09 P/Share
|
|
Mar 15
2023
|
Beth C Seidenberg |
BUY
Open market or private purchase
|
Indirect |
32,844
+1.82%
|
$229,908
$7.12 P/Share
|
|
Mar 14
2023
|
Sean Grant CHIEF FINANCIAL OFFICER |
BUY
Bona fide gift
|
Indirect |
14,285
+48.32%
|
-
|
|
Mar 14
2023
|
Sean Grant CHIEF FINANCIAL OFFICER |
SELL
Bona fide gift
|
Direct |
14,285
-28.61%
|
-
|
|
Mar 10
2023
|
Beth C Seidenberg |
BUY
Open market or private purchase
|
Indirect |
48,003
+2.69%
|
$336,021
$7.16 P/Share
|
|
Mar 03
2023
|
Beth C Seidenberg |
BUY
Open market or private purchase
|
Indirect |
1,000
+0.06%
|
$7,000
$7.25 P/Share
|
|
Mar 02
2023
|
Beth C Seidenberg |
BUY
Open market or private purchase
|
Indirect |
23,378
+1.37%
|
$163,646
$7.24 P/Share
|
|
Mar 01
2023
|
Beth C Seidenberg |
BUY
Open market or private purchase
|
Indirect |
100
+0.01%
|
$700
$7.25 P/Share
|
|
Feb 23
2023
|
Beth C Seidenberg |
BUY
Open market or private purchase
|
Indirect |
200
+0.01%
|
$1,400
$7.24 P/Share
|
|
Feb 13
2023
|
Beth C Seidenberg |
BUY
Open market or private purchase
|
Indirect |
10,072
+0.6%
|
$70,504
$7.2 P/Share
|
|
Feb 09
2023
|
Beth C Seidenberg |
BUY
Open market or private purchase
|
Indirect |
400
+0.02%
|
$2,800
$7.25 P/Share
|
|
Feb 08
2023
|
Beth C Seidenberg |
BUY
Open market or private purchase
|
Indirect |
45,357
+2.67%
|
$317,499
$7.22 P/Share
|
|
Feb 07
2023
|
Beth C Seidenberg |
BUY
Open market or private purchase
|
Indirect |
87,956
+5.18%
|
$615,692
$7.08 P/Share
|
|
Feb 06
2023
|
Beth C Seidenberg |
BUY
Open market or private purchase
|
Indirect |
131,602
+7.96%
|
$921,214
$7.03 P/Share
|
|
Feb 06
2023
|
Longitude Capital Partners Iv, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,714,285
+50.0%
|
$11,999,995
$7.0 P/Share
|
|
Feb 06
2023
|
Patrick G Enright |
BUY
Open market or private purchase
|
Indirect |
1,714,285
+50.0%
|
$11,999,995
$7.0 P/Share
|
|
Feb 06
2023
|
Sofinnova Venture Partners X, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
285,714
+7.61%
|
$1,999,998
$7.0 P/Share
|
|
Feb 03
2023
|
Beth C Seidenberg |
BUY
Open market or private purchase
|
Indirect |
46,163
+3.22%
|
$323,141
$7.24 P/Share
|